¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"5% Fructose Injection 1000mL"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • injection molding method
    »çÃ⼺Çü¹ý
  • intra-arterial injection
    µ¿¸Æ³»ÁÖ»ç
  • intracameral injection
    ¾Õ¹æ³»ÁÖ»ç, Àü¹æ³»ÁÖ»ç
  • intracardiac injection
    ½ÉÀå³»ÁÖ»ç
  • intracutaneous injection
    ÇǺγ»ÁÖ»ç, Çdz»ÁÖ»ç
  • intracytoplasmic sperm injection
    ¼¼Æ÷Áú³»Á¤ÀÚÁÖÀÔ
  • intradermal injection
    ÇǺγ»ÁÖ»ç, Çdz»ÁÖ»ç
  • intramuscular injection
    ±ÙÀ°³»ÁÖ»ç, ±ÙÀ°ÁÖ»ç
  • intraperitoneal injection
    º¹°­³»ÁÖ»ç, ¹è¸·¾ÈÁÖ»ç
  • intrapleural injection
    °¡½¿¸·¾ÈÁÖ»ç, Èä°­³»ÁÖ»ç
  • jet injection
    ºÐ»çÁÖ»ç
  • preparatory injection
    ÁغñÁÖ»ç
  • provocative injection
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • paravertebral injection
    ôÃß¿·ÁÖ»ç
  • percutaneous ethanol injection
    ÇǺΰæÀ¯¿¡Åº¿ÃÁÖ»ç, °æÇÇ¿¡Åº¿ÃÁÖ»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intra-arterial injection
    µ¿¸Æ³»ÁÖ»ç
  • intracameral injection
    ¾Õ¹æ³»ÁÖ»ç
  • intracardiac injection
    ½ÉÀå³»ÁÖ»ç
  • intracutaneous injection
    (¢¡intradermal injection) ÇǺγ»ÁÖ»ç
  • intracytoplasmic sperm injection
    ¼¼Æ÷Áú³»Á¤ÀÚÁÖÀÔ
  • intradermal injection
    ÇǺγ»ÁÖ»ç
  • intramuscular injection
    ±ÙÀ°³»ÁÖ»ç
  • intraperitoneal injection
    º¹¸·¾ÈÁÖ»ç, º¹°­³»ÁÖ»ç
  • intrapleural injection
    °¡½¿¸·°ø°£ÁÖ»ç, È丷°­³»ÁÖ»ç
  • intravascular injection
    Ç÷°ü³»ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³»ÁÖ»ç
  • jet injection
    ºÐ»çÁÖ»ç
  • paravertebral injection
    ôÃßÁÖÀ§ÁÖ»ç
  • preparatory injection
    ÁغñÁÖ»ç
  • provocative injection
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • injection aerator
    ºÐ»ç½ÄÆø±âÀåÄ¡(ËÓË×Ëà̰˻Ëö̬).
  • injection cast corrosion method
    Ç÷°üÁÖÇüÀÛÁ¦¹ý.
  • injection molding method
    »çÃ⼺Çü¹ý(ÞÒõóà÷úþÛö).
  • injection, booster
    Ãß°¡Á¢Á¾, Ãß°¡ÁÖ»ç
  • injection, eliciting
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • injection, provocative
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • pre/post gadolinium injection
    Àü/ÈÄ °¡µ¹¸®´½ ÁÖÀÔ
  • preparatory injection
    ÁغñÁÖ»ç(¡­ñ¼ÞÒ).
  • provocative injection
    À¯¹ßÁÖ»ç(ë¯Û¡ñ¼ÞÒ).
  • rapid injection
    ±Þ¼ÓÁÖÀÔ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • booster injection
    ºÎ¿ì½ºÅÍÁÖ»ç(¡­ñ¼ÞÒ), Ãß°¡Á¢Á¾(õÚÊ¥ïÈðú).
  • cavernosal injection
    ÇØ¸éü ÁÖÀÔ(ÁÖ»ç)
  • ciliary injection
    ¸ð¾çÃæÇ÷(¡­õöúì).
  • circumcorneal injection
    °¢¸·ÁÖÀ§ÃæÇ÷, ¸ð¾çÃæÇ÷
  • collagen injection
    Äݶó°Õ ÁÖÀÔ(ÁÖ»ç)
  • conjunctival injection
    °á¸·ÃæÇ÷(¡­õöúì).
  • dental injection needle
    Ä¡°ú¿ë ÁÖ»çħ(¡­ñ¼ÞÒöÜ).
  • endermic injection
    Çdz»ÁÖ»ç(¡­ñ¼ÞÒ).
  • endodermic injection
    Çdz»ÁÖ»ç(¡­ñ¼ÞÒ).
  • epifascial injection
    ±Ù¸·¿Ü ÁÖ»ç(ÐÉØ¯èâ ñ¼ÞÒ), ±Ù¸·»ó ÁÖ»ç(¡­ñ¼ÞÒ).
  • exciting injection
    °¨ÀÛÁÖ»ç(ÊïíÂñ¼ÞÒ).
  • extravascular injection
    Ç÷°ü¿ÜÁÖ»ç.
  • fine injection
    ¹Ì¼¼¸Æ°üÁÖ»ç.
  • hypodermic injection
    ÇÇÇÏÁÖ»ç.
  • injection
    ÁÖ»ç,ÁÖÀÔ,ÃæÇ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FMP faculty mentorship program; first menstrual period; fructose monophosphate
F1P, F-1-P fructose-1-phosphate
F6P, F-6-P fructose-6-phosphate
FPK fructose phosphokinase
Fru fructose
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FBP Fructose 1,6-biphosphate
FBPase fructose-1,6-biophosphatases
FDPase Fructose-1,6-diphosphatase
F-1-P Fructose-1-phosphate
GFOR Glucose-fructose oxidoreductase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • interligamentary injection syringe
    Ä¡±Ù¸·³» ÁÖÀÔ¿ë ÁÖ»ç±â
  • intra-arterial injection
    µ¿¸Æ³» ÁÖ»ç
  • intraarticular injection
    °üÀý³» ÁÖ»ç
  • intracutaneous injection
    Çdz» ÁÖ»ç
    Çdz»¿¡ ¾à¹°À» ÁÖÀÔÇÏ´Â ¹æ¹ýÀ¸·Î Áúº´ÀÇ Áø´Ü ¹× ¿¹¹æÀ» À§ÇØ Èí¼ö¸¦ ´À¸®°Ô ÇÏ°í ¾àÈ¿¸¦ °¡´ÉÇÑÇÑ Áö¼Ó½Ã۱⸦ ¹Ù¶ó´Â °æ¿ì ¹× ´Ù¸¥ ÁÖ»ç¹ýÀ¸·Î¼­´Â ºÎÀû´çÇÑ ¾àÁ¦ÀÇ °æ¿ì µî¿¡ ÇàÇØÁø´Ù. ¸¹Àº °æ¿ì ¹ÝÀÀÀÌ ´«À¸·Î º¸Àδٴ Ư¡ÀÌ ÀÖ´Ù.
  • intramuscular injection
    ±Ù³» ÁÖ»ç, ±ÙÀ°³» ÁÖ»ç, ±ÙÀ° ÁÖ»ç
    ¾àÁ¦¸¦ ±ÙÀ°¿¡ ÁÖ»çÇÏ´Â °Í. ÇÇÇÏ Áֻ翡 ºñÇØ¼­ Èí¼ö°¡ ºü¸£°í 2-5mlÀ» Àû¿ëÇÒ ¼ö ÀÖ´Ù. ÀÚ±Ø, ÅëÁõÀÌ °­ÇÑ °ÍÀ̳ª À¯¼ºÀÇ ¾àÁ¦ µî ¶Ç Èí¼ö°¡ ³ª»Û °ÍÀÌ ±ÙÀ° Áֻ翡¼­ Àû¿ëµÈ´Ù.
  • intraosseous, interseptal, intrapulpal injection
    °ñ³», Á߰ݰ£, Ä¡¼ö³» ÁÖ»ç
  • intrapulpal injection
    Ä¡¼ö ³» ÁÖ»ç
  • intravascular injection
    Ç÷°ü³» ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³» ÁÖ»ç
  • mercurophylline injection
    ¸ÓÅ¥·ÎÇʸ° ÁÖ»ç¾×
  • paraperiosteal injection
    °ñ¸· ÁÖÀ§ ÁÖ»ç
  • paravertebral injection
    ôÃß ÁÖÀ§ ÁÖ»ç
  • post-injection trismus
    ÁÖ»ç ÈÄ ¾Æ°ü±ä±Þ
  • pre/post gadolinium injection
    °¡µ¹¸®´½ ÁÖÀÔÀü/ÈÄ
  • retrogasserian injection of glycerol

    retrogasserian neurotomy (°¡¼¼¸£ ½Å°æÀý Èı٠Àý´Ü¼ú

CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
fructose-2,6-bisphosphate 6-phosphatase <enzyme> Do not confuse with fructose-2,6-bisphosphate 2-phosphatase (EC 3.1.3.46)
Registry number: EC 3.1.3.54
Synonym: fdp 6-phosphatase, fru(2,6)p2 6-phosphatase
(26 Jun 1999)
fructose 6-phosphate <biochemistry> A phosphorylated six-carbon sugar formed in the second step of glycolysis by the action of phosphoglucose isomerase on glucose-6-phosphate. In the third step, fructose 6-phospate and ATP are used to create fructose 1,6-biphosphate, ADP and a free hydrogen with the aid of phosphofructokinase.
(08 Mar 2000)
fructose-6-phosphate phosphoketolase <enzyme> Catalyses the conversion of d-fructose 6-phosphate and orthophosphate to acetylphosphate and d-erythrose 4-phosphate and water
Registry number: EC 4.1.2.22
Synonym: f6p phosphoketolase
(26 Jun 1999)
fructose-bisphosphatase <enzyme> An enzyme that catalyses the conversion of d-fructose 1,6-bisphosphate and water to d-fructose 6-phosphate and orthophosphate.
Chemical name: D-Fructose-1,6-bisphosphate 1-phosphohydrolase
Registry number: EC 3.1.3.11
(12 Dec 1998)
fructose-bisphosphate aldolase <enzyme> An enzyme of the lyase class that catalyses the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3s,4r)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (enzyme nomenclature, 1992) e.c. 4.1.2.13.
Chemical name: D-Fructose-1,6-biphosphate D-glyceraldehyde-3-phosphate-lyase
Registry number: EC 4.1.2.13
(12 Dec 1998)
fructose-diphosphate aldolase <enzyme> An enzyme of the lyase class that catalyses the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3s,4r)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (enzyme nomenclature, 1992) e.c. 4.1.2.13.
Chemical name: D-Fructose-1,6-biphosphate D-glyceraldehyde-3-phosphate-lyase
Registry number: EC 4.1.2.13
(12 Dec 1998)
fructose intolerance An autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (ec 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycaemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.
(12 Dec 1998)
fructose metabolism, inborn errors Inherited abnormalities of fructose metabolism, which include three known autosomal recessive types: hepatic fructokinase deficiency (essential fructosuria), hereditary fructose intolerance, and hereditary fructose-1,6-diphosphatase deficiency. Essential fructosuria is a benign asymptomatic metabolic disorder caused by deficiency in fructokinase, leading to decreased conversion of fructose to fructose-1-phosphate and alimentary hyperfructosaemia, but with no clinical dysfunction; may produce a false-positive diabetes test.
(12 Dec 1998)
fructose permease <chemical> Fructose-specific enzyme II of phosphoenolpyruvate-dependent phosphotransferase system in e. Coli
(26 Jun 1999)
adrenal cortex injection An obsolete treatment involving the parenteral administration of extract of the adrenal cortex; formerly used in treatment of Addison's disease.
(05 Mar 2000)
bolus injection <procedure> The injection of a drug (or drugs) in a high quantity (called a bolus) at once, the opposite of gradual administration (as in intravenous infusion).
(18 Nov 1997)
regular insulin injection A preparation that may contain 20, 40, 80, 100, or 500 USP insulin units per ml, although the trend is toward standardizing all insulin preparations at 100 units per ml; it is administered subcutaneously, occasionally intravenously, and has a rapid onset of action, has a brief duration (5 to 7 hours), and is compatible for mixing with long-acting insulin preparations; used in the treatment of diabetic acidosis and insulin coma.
Synonym: regular insulin injection.
(05 Mar 2000)
Ringer's injection A sterile solution of sodium chloride, potassium chloride, and calcium chloride, containing in each 100 ml between 820 and 900 mg of sodium chloride, between 25 and 35 mg of potassium chloride, and between 30 and 37 mg of calcium chloride; used intravenously as a fluid and electrolyte replenisher.
(05 Mar 2000)
water for injection Water purified by distillation for the preparation of products for parenteral use.
(05 Mar 2000)
collagen injection Correction of superficial soft tissue deformities, acne scars, or age-related skin changes by injection (implantation) of collagen; bovine collagen preparations are commonly used. Prior intradermal testing is necessary to exclude hypersensitivity.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á